China Approves Fifth Domestic PD-1 Drug

Just Misses Out On Annual Price Negotiations

Akeso/Sino Biopharm's pd-1 approval
The addition makes China's domestic pd-1 market even more crowded • Source: Alamy

More from New Products

More from Scrip